Accretion Nutraveda Share Price | Accretion Nutraveda Stock Screener
ANL
Pharmaceuticals
Track Accretion Nutraveda share price live with TickJournal's free stock screener.
Analyse ANL share price history and track historical price performance.
Use the Accretion Nutraveda stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Accretion Nutraveda Market Cap
₹194.60 Cr.
ANL P/E Ratio (TTM)
-
Accretion Nutraveda P/B Ratio
6.34
EPS (TTM)
₹9.35
Dividend Yield
-
Debt to Equity
0.94
ANL 52 Week High
-
Accretion Nutraveda 52 Week Low
-
Operating Margin
-
Profit Margin
-
ANL Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹42.00
Total Equity
₹36.00
Accretion Nutraveda Share Price Chart
Screen Accretion Nutraveda share price with an interactive chart. Analyse ANL price trends and volatility across different timeframes.
Accretion Nutraveda Company Profile - Fundamental Screener
Screen Accretion Nutraveda company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ANL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE1KVQ01019
Accretion Nutraveda Balance Sheet Screener
Screen ANL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 42 | 11 | 5 | 4 |
| Current Assets | 36 | 9 | 3 | 3 |
| Fixed Assets | 2 | 2 | 1 | 2 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 36 | 5 | 1 | 0 |
| Share Capital | 7 | 1 | 0 | 0 |
| Reserves & Surplus | 28 | 5 | 1 | 0 |
Accretion Nutraveda Income Statement Screener - Profit & Revenue Analysis
Screen Accretion Nutraveda income statement and profit fundamentals.
Analyze ANL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Accretion Nutraveda share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|---|
| Revenue | 0 | 34 | 16 | 5 | 3 |
| Expenses | 0 | 27 | 12 | 4 | 2 |
| EBITDA | 0 | 7 | 4 | 1 | 1 |
| Operating Profit % | 0.00% | 21.00% | 23.00% | 24.00% | 21.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 6 | 3 | 1 | 0 |
| Tax | 0 | 1 | 1 | 0 | 0 |
| Net Profit | 0 | 5 | 3 | 1 | 0 |
| EPS | 0.00 | 9.35 | 71.91 | 22.83 | 7.79 |
Accretion Nutraveda Cash Flow Screener - Liquidity Fundamentals
Screen ANL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | -2 | 0 | 1 |
| Investing Activities | -1 | 0 | 0 |
| Financing Activities | 3 | 0 | -1 |
| Net Cash Flow | 0 | 0 | 0 |
Accretion Nutraveda Shareholding Pattern Screener
See Accretion Nutraveda shareholding pattern with promoter, FII, and DII holdings.
Check Accretion Nutraveda promoter holding and ownership changes for ANL on TickJournal.
| Item | 2026-Jan | 2026-Feb | 2026-Mar | 2025-Sept |
|---|---|---|---|---|
| Promoter Holding | 100.00% | 73.48% | 73.48% | 100.00% |
| FII Holding | 0.00% | 6.04% | 1.08% | 0.00% |
| DII Holding | 0.00% | 6.51% | 7.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 10.48% | 14.19% | 0.00% |
| Other Holding | 0.00% | 3.49% | 4.25% | 0.00% |
| Shareholder Count | 10 | 407 | 427 | 10 |
Accretion Nutraveda Share Dividend Screener - Share Yield Analysis
Check Accretion Nutraveda dividend history with payout and yield data.
View Accretion Nutraveda dividend details including ex-dates and amounts for ANL stock.
Accretion Nutraveda Stock Index Membership
See which indices include Accretion Nutraveda stock.
Check ANL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Accretion Nutraveda Market Events Screener - Corporate Actions
Get Accretion Nutraveda corporate actions including splits, bonuses, and buybacks.
Check Accretion Nutraveda stock events that may affect ANL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | 1.57% |
Accretion Nutraveda Competitors Screener - Peer Comparison
Screen ANL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,044 | 38.83 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 174,400 | 68.00 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 155,834 | 73.17 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 116,895 | 30.65 | 29,045 | 2.24% | 3,870 | 69.96 |
| Zydus Life Science | 111,793 | 21.84 | 26,720 | 13.65% | 5,242 | 62.64 |
| Dr Reddys Laboratories | 111,512 | 27.24 | 33,593 | -0.44% | 3,998 | 66.21 |
| Lupin | 109,745 | 20.66 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 103,885 | 54.26 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 89,494 | 26.13 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 80,525 | 92.10 | 6,868 | 22.01% | 890 | 72.35 |
Accretion Nutraveda Company Announcements - News Screener
Screen ANL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-08 | Appointment Of Internal Auditors | - |
| 2026-05-08 | Appointment Of Secretarial Auditors | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-05-08 | Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 2026 | - |
| 2026-05-01 | Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026 | - |
| 2026-04-30 | Clarification On Price Movement | - |
| 2026-04-29 | Clarification sought from Accretion Nutraveda Ltd | - |
| 2026-04-29 | Confirmation Regarding Non-Applicability Of Large Corporate Disclosure Requirements | - |
| 2026-04-27 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-01 | Intimation For Change Of Corporate Identification Number (CIN) Of The Company. | - |
| 2026-03-28 | Closure of Trading Window | - |
| 2026-03-26 | Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-26 | Appointment Of Internal Auditors | - |
| 2026-03-26 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-02-20 | Clarification On Price Movement | - |